{"id":26387,"date":"2024-08-08T16:25:10","date_gmt":"2024-08-08T23:25:10","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=26387"},"modified":"2024-08-08T16:25:13","modified_gmt":"2024-08-08T23:25:13","slug":"gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/","title":{"rendered":"Gilenya (Fingolimod): Terapia oral modificadora de la enfermedad para la esclerosis m\u00faltiple (EM)"},"content":{"rendered":"<p>Gilenya es un medicamento con receta.<em> <\/em>que se utiliza para tratar las formas recurrentes-remitentes de <a href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/10-tips-for-living-with-multiple-sclerosis\/\">esclerosis m\u00faltiple (EM)<\/a> <em>\u2014 <\/em>un trastorno neurol\u00f3gico inmunomediado que se produce debido a un da\u00f1o a los nervios en el cerebro y la m\u00e9dula espinal.\u00a0<\/p>\n\n\n\n<div  id=\"call-to-action-6844e72dbcfa92db76c624ab185015c6\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia financiera\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>Este medicamento pertenece a los inmunosupresores.<em> <\/em>Clase de f\u00e1rmaco que suprime el sistema inmunitario en puntos espec\u00edficos para prevenir o reducir el da\u00f1o nervioso. Fue la primera terapia modificadora de la enfermedad (TME) aprobada por... <a href=\"https:\/\/www.fda.gov\/\">FDA<\/a> en 2010 para reducir las reca\u00eddas y retrasar la progresi\u00f3n de la enfermedad en pacientes con esclerosis m\u00faltiple recurrente-remitente (EMRR).\u00a0<\/p>\n\n\n\n<p>El nombre gen\u00e9rico de Gilenya es fingolimod<em>.&nbsp;<\/em><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#What_Forms_of_Multiple_Sclerosis_MS_Is_Gilenya_Used_To_Treat\" >\u00bfQu\u00e9 formas de esclerosis m\u00faltiple (EM) se tratan con Gilenya?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#Relapsing-Remitting_MS_RRMS\" >Esclerosis m\u00faltiple remitente-recurrente (EMRR)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#Clinically_Isolated_Syndrome_CIS\" >S\u00edndrome cl\u00ednicamente aislado (CIS)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#Active_Secondary_Progressive_MS\" >Esclerosis m\u00faltiple progresiva secundaria activa<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#When_Is_Gilenya_Prescribed_to_Patients\" >\u00bfCu\u00e1ndo se prescribe Gilenya a los pacientes?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#How_Does_It_Work\" >\u00bfC\u00f3mo funciona?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#Mechanism_of_Action\" >Mecanismo de acci\u00f3n<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#In_What_Drug_Form_Is_Gilenya_Available\" >\u00bfEn qu\u00e9 forma de medicamento est\u00e1 disponible Gilenya?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#What_Is_the_Recommended_Dose\" >\u00bfCu\u00e1l es la dosis recomendada?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#Recommended_Dose_for_Adults\" >Dosis recomendada para adultos<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#Recommended_Dose_for_Pediatric_Patients\" >Dosis recomendada para pacientes pedi\u00e1tricos<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#How_Is_Gilenya_Taken\" >\u00bfC\u00f3mo se toma Gilenya?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#Side_Effects\" >\u00bfEfectos secundarios?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#Common_or_Mild_Side_Effects\" >Efectos secundarios comunes o leves<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#Serious_Side_Effects\" >Efectos secundarios graves<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#What_Special_Precautions_Should_You_Follow_Before_Taking_Gilenya\" >\u00bfQu\u00e9 precauciones especiales debe seguir antes de tomar Gilenya?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#What_You_Should_Avoid_When_Taking_Gilenya\" >Lo que debe evitar al tomar Gilenya<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#Cost\" >Costo<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Forms_of_Multiple_Sclerosis_MS_Is_Gilenya_Used_To_Treat\"><\/span><strong>\u00bfQu\u00e9 formas de esclerosis m\u00faltiple (EM) se tratan con Gilenya?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Gilenya se utiliza para tratar las formas recurrentes de esclerosis m\u00faltiple (EM), que incluyen:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Relapsing-Remitting_MS_RRMS\"><\/span><strong>Esclerosis m\u00faltiple remitente-recurrente (EMRR)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>En este formulario, un paciente tiene <a href=\"https:\/\/health.clevelandclinic.org\/ms-flare-up\">brotes<\/a> (reca\u00eddas) de s\u00edntomas seguidos de un per\u00edodo con s\u00edntomas m\u00e1s leves o sin s\u00edntomas (fase de remisi\u00f3n).&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Clinically_Isolated_Syndrome_CIS\"><\/span><strong>S\u00edndrome cl\u00ednicamente aislado (CIS)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Esta condici\u00f3n se refiere a un episodio de uno o dos s\u00edntomas neurol\u00f3gicos que indican la aparici\u00f3n de EM.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Active_Secondary_Progressive_MS\"><\/span><strong>Esclerosis m\u00faltiple progresiva secundaria activa<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La EM secundaria progresiva activa se desarrolla tras la fase recurrente-remitente de la EM. En esta etapa, los pacientes experimentan menos reca\u00eddas que con EMRR, pero sus s\u00edntomas empeoran con el tiempo a pesar del tratamiento.&nbsp;<\/p>\n\n\n\n<p>Gilenya se utiliza en adultos y ni\u00f1os mayores de 10 a\u00f1os con una forma recurrente de EM.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"When_Is_Gilenya_Prescribed_to_Patients\"><\/span><strong>\u00bfCu\u00e1ndo se prescribe Gilenya a los pacientes?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Gilenya generalmente se prescribe a pacientes en las siguientes condiciones:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Cuando otros <a href=\"https:\/\/www.nationalmssociety.org\/for-professionals\/for-healthcare-professionals\/managing-and-treating-ms\/disease-modification\">terapias modificadoras de la enfermedad<\/a> (DMT) no funcionan y los pacientes a\u00fan experimentan m\u00e1s de dos reca\u00eddas incapacitantes en un a\u00f1o<\/li>\n\n\n\n<li>Cuando su resonancia magn\u00e9tica muestra un mayor n\u00famero de lesiones en el cerebro<\/li>\n\n\n\n<li>Cuando tiene esclerosis m\u00faltiple recurrente muy activa o esclerosis m\u00faltiple remitente-recurrente grave<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_It_Work\"><\/span><strong>\u00bfC\u00f3mo funciona?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>En la EM, c\u00e9lulas inmunitarias como las c\u00e9lulas T y B (producidas en los ganglios linf\u00e1ticos) viajan al cerebro y la m\u00e9dula espinal y destruyen la capa protectora (vaina de mielina) de las c\u00e9lulas nerviosas. Gilenya act\u00faa para reducir este da\u00f1o nervioso limitando el movimiento de estas c\u00e9lulas inmunitarias al cerebro.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mechanism_of_Action\"><\/span><strong>Mecanismo de acci\u00f3n<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>El principio activo de Gilenya, fingolimod, es un modulador del receptor de esfingosina-1-fosfato que se une y bloquea la acci\u00f3n del receptor de esfingosina-1-fosfato (S1P) en los linfocitos (c\u00e9lulas T y B). Los receptores S1P controlan principalmente el movimiento de los linfocitos en el organismo.&nbsp;<\/p>\n\n\n\n<p>Al bloquear el receptor SIP, Gilenya impide que los linfocitos abandonen los ganglios linf\u00e1ticos y ataquen las c\u00e9lulas nerviosas. Esto ayuda a reducir la gravedad de los s\u00edntomas y a ralentizar la progresi\u00f3n de la enfermedad.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"In_What_Drug_Form_Is_Gilenya_Available\"><\/span><strong>\u00bfEn qu\u00e9 forma de medicamento est\u00e1 disponible Gilenya?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Gilenya est\u00e1 disponible en c\u00e1psulas duras orales en concentraciones de 0,5 y 0,25 mg.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_the_Recommended_Dose\"><\/span><strong>\u00bfCu\u00e1l es la dosis recomendada?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La dosis de Gilenya se ajusta seg\u00fan el peso del paciente (kg). Se toma una vez al d\u00eda.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recommended_Dose_for_Adults\"><\/span><strong>Dosis recomendada para adultos<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Para un paciente adulto que pese m\u00e1s de 40 kg, se debe tomar 0,5 mg (una c\u00e1psula oral) de Gilenya una vez al d\u00eda.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recommended_Dose_for_Pediatric_Patients\"><\/span><strong>Dosis recomendada para pacientes pedi\u00e1tricos<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Si un paciente pedi\u00e1trico (de 10 a\u00f1os de edad o mayor) pesa m\u00e1s de 40 kg, se recomienda 0,5 mg (una c\u00e1psula oral) de Gilenya.&nbsp;<\/p>\n\n\n\n<p>Sin embargo, si su peso es menor o igual a 40 kg, entonces se recomienda una dosis de 0,25 mg (una c\u00e1psula oral) de Gilenya.\u00a0<\/p>\n\n\n\n<div  id=\"call-to-action-dbe23367d973b130eaca937a92a9f16f\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Is_Gilenya_Taken\"><\/span><strong>\u00bfC\u00f3mo se toma Gilenya?<\/strong><strong>?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Gilenya se toma por v\u00eda oral, con o sin alimentos. Se recomienda tomar la primera dosis de Gilenya en un centro m\u00e9dico, ya que este medicamento puede disminuir la frecuencia card\u00edaca. El profesional de la salud monitorear\u00e1 su estado durante 6 horas despu\u00e9s de tomar el medicamento para detectar cualquier problema.\u00a0<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Side_Effects\"><\/span><strong>\u00bfEfectos secundarios?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Gilenya puede provocar efectos secundarios leves y potencialmente graves.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Common_or_Mild_Side_Effects\"><\/span><strong>Efectos secundarios comunes o leves<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cough.jpg\" alt=\"Woman coughing as a side effect of taking Gilenya\" class=\"wp-image-26392\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cough.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cough-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cough-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cough-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cough-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cough-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/cough-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>Los efectos secundarios m\u00e1s comunes incluyen:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Dolor de cabeza<\/li>\n\n\n\n<li>Aumento de las enzimas hep\u00e1ticas<\/li>\n\n\n\n<li>Diarrea<\/li>\n\n\n\n<li>Tos<\/li>\n\n\n\n<li>Influenza<\/li>\n\n\n\n<li>Sinusitis<\/li>\n\n\n\n<li>Dolor de espalda<\/li>\n\n\n\n<li>Dolor abdominal y dolor en las extremidades (brazos o piernas)<\/li>\n\n\n\n<li>N\u00e1useas<\/li>\n<\/ul>\n\n\n\n<p>Estos efectos secundarios generalmente son temporales y duran unos d\u00edas o semanas.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Serious_Side_Effects\"><\/span><strong>Efectos secundarios graves<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Es menos com\u00fan, pero Gilenya tambi\u00e9n causa algunos efectos secundarios graves, que son los siguientes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Problema grave del ritmo card\u00edaco (frecuencia card\u00edaca lenta)<\/li>\n\n\n\n<li>Infecciones cerebrales como <a href=\"https:\/\/www.ninds.nih.gov\/health-information\/disorders\/progressive-multifocal-leukoencephalopathy\">leucoencefalopat\u00eda multifocal progresiva (LMP)<\/a><\/li>\n\n\n\n<li>Hipertensi\u00f3n (presi\u00f3n arterial alta)<\/li>\n\n\n\n<li><a href=\"https:\/\/www.nei.nih.gov\/learn-about-eye-health\/eye-conditions-and-diseases\/macular-edema\">Edema macular<\/a><\/li>\n\n\n\n<li>da\u00f1o hep\u00e1tico<\/li>\n\n\n\n<li>Neoplasias malignas de la piel como el melanoma y el carcinoma basocelular<\/li>\n\n\n\n<li>Reacci\u00f3n al\u00e9rgica<\/li>\n\n\n\n<li>Hinchaz\u00f3n en el cerebro (una afecci\u00f3n conocida como s\u00edndrome de encefalopat\u00eda posterior reversible)<\/li>\n\n\n\n<li>EM tumefactiva (una forma rara de EM que causa masas o lesiones similares a tumores en el cerebro)<\/li>\n\n\n\n<li>Dificultad para respirar (problemas respiratorios)<\/li>\n<\/ul>\n\n\n\n<p>Si experimenta alguno de los efectos secundarios mencionados anteriormente, visite a su proveedor de atenci\u00f3n m\u00e9dica de inmediato.\u00a0<\/p>\n\n\n\n<div  id=\"call-to-action-14d586e5b768a7f0ba85a0fb4f9f6f8e\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Special_Precautions_Should_You_Follow_Before_Taking_Gilenya\"><\/span><strong>\u00bfQu\u00e9 precauciones especiales debe seguir antes de tomar Gilenya?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Antes de tomar Gilenya, es importante informar a su profesional de la salud si padece alguna afecci\u00f3n m\u00e9dica o est\u00e1 tomando otros medicamentos. Es especialmente importante informar a su m\u00e9dico si:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u00bfEst\u00e1 embarazada o planea quedar embarazada?<\/li>\n\n\n\n<li>Est\u00e1 amamantando o planea amamantar\u00a0<\/li>\n\n\n\n<li>Tiene antecedentes de problemas card\u00edacos, como un ataque card\u00edaco, insuficiencia card\u00edaca, accidente cerebrovascular o arritmia (frecuencia o ritmo card\u00edaco irregular).<\/li>\n\n\n\n<li>Tiene antecedentes de problemas hep\u00e1ticos.<\/li>\n\n\n\n<li>Tiene diabetes o c\u00e1ncer de piel.<\/li>\n\n\n\n<li>Tiene uve\u00edtis (una forma de inflamaci\u00f3n ocular)\u00a0<a href=\"https:\/\/www.medicalnewstoday.com\/articles\/248423\">inflamaci\u00f3n<\/a>)<\/li>\n\n\n\n<li>Tiene fiebre o una infecci\u00f3n grave activa.<\/li>\n\n\n\n<li>Ha recibido una vacuna viva (como la vacuna contra el sarampi\u00f3n, las paperas y la rub\u00e9ola) en los \u00faltimos 2 meses<\/li>\n\n\n\n<li>\u00bfEst\u00e1 tomando medicamentos de venta libre, suplementos o productos a base de hierbas?<\/li>\n\n\n\n<li>Es al\u00e9rgico a alg\u00fan componente de Gilenya.\u00a0<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_You_Should_Avoid_When_Taking_Gilenya\"><\/span><strong>Lo que debe evitar al tomar Gilenya<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Debes evitar tomar medicamentos como los sist\u00e9micos. <a href=\"https:\/\/www.mayoclinic.org\/drugs-supplements\/ketoconazole-topical-route\/description\/drg-20067739\">Ketoconazol<\/a> Al tomar Gilenya, ya que puede aumentar el riesgo de problemas card\u00edacos. Adem\u00e1s, evite las vacunas vivas durante y 2 meses despu\u00e9s de suspender Gilenya, ya que pueden aumentar el riesgo de infecci\u00f3n.&nbsp;<\/p>\n\n\n\n<p>Gilenya tambi\u00e9n puede aumentar el riesgo de c\u00e1ncer de piel. Por lo tanto, es importante evitar la luz solar o las camas solares y usar siempre protector solar (FPS 30 o superior) al salir.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cost\"><\/span><strong>Costo<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Gilenya es un medicamento de marca que puede ser algo caro. Una c\u00e1psula de 0,5 mg cuesta alrededor de $373, y un suministro de 30 c\u00e1psulas cuesta alrededor de $11,204.&nbsp;<\/p>\n\n\n\n<p>El costo puede variar seg\u00fan la farmacia que visite. Los pacientes con bajos ingresos o sin seguro m\u00e9dico pueden participar en programas de asistencia al paciente para reducir el costo del tratamiento.&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Gilenya es un medicamento recetado que se utiliza para tratar las formas recurrentes y remitentes de la esclerosis m\u00faltiple (EM), un trastorno neurol\u00f3gico inmunomediado que se produce debido al da\u00f1o a los nervios en el cerebro y la m\u00e9dula espinal.\u00a0<\/p>","protected":false},"author":7,"featured_media":26390,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[26],"tags":[8],"class_list":["post-26387","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis","tag-dr-christine-leduc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gilenya (Fingolimod): Oral Disease-Modifying Therapy for Multiple Sclerosis (MS)<\/title>\n<meta name=\"description\" content=\"Learn about how Gilenya treats relapsing-remitting forms of multiple sclerosis. Topics include how the drug works, side effects, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilenya (Fingolimod): Oral Disease-Modifying Therapy for Multiple Sclerosis (MS)\" \/>\n<meta property=\"og:description\" content=\"Learn about how Gilenya treats relapsing-remitting forms of multiple sclerosis. Topics include how the drug works, side effects, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-08T23:25:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-08T23:25:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Christine Leduc, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Christine Leduc, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\\\/\"},\"author\":{\"name\":\"Dr. Christine Leduc, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\"},\"headline\":\"Gilenya (Fingolimod): Oral Disease-Modifying Therapy for Multiple Sclerosis (MS)\",\"datePublished\":\"2024-08-08T23:25:10+00:00\",\"dateModified\":\"2024-08-08T23:25:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\\\/\"},\"wordCount\":1014,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/ms-ribbon.jpg\",\"keywords\":[\"Dr. Christine Leduc\"],\"articleSection\":[\"Multiple Sclerosis\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\\\/\",\"name\":\"Gilenya (Fingolimod): Oral Disease-Modifying Therapy for Multiple Sclerosis (MS)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/ms-ribbon.jpg\",\"datePublished\":\"2024-08-08T23:25:10+00:00\",\"dateModified\":\"2024-08-08T23:25:13+00:00\",\"description\":\"Learn about how Gilenya treats relapsing-remitting forms of multiple sclerosis. Topics include how the drug works, side effects, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/ms-ribbon.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/ms-ribbon.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Doctor holding orange ribbon for multiple sclerosis awareness\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilenya (Fingolimod): Oral Disease-Modifying Therapy for Multiple Sclerosis (MS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\",\"name\":\"Dr. Christine Leduc, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"caption\":\"Dr. Christine Leduc, PharmD\"},\"description\":\"Dr. Christine Leduc, PharmD, was born and raised in Irvine, CA. She attended college at Midwestern University, where she graduated cum laude. The most rewarding part of her job is suggesting lifestyle changes, educating patients on how their medication works, and precepting future pharmacists. Her areas of expertise are customer service and knowledge of specialty medication. Having worked in the service industry in the past, she has gained the customer service skills necessary to understand the needs of her patients. Dr. Leduc is currently precepting students from Marshall B. Ketchum University, University of Kansas, and Midwestern University. In her free time, she enjoys traveling, baking, and gardening. See Author Biography\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/christine-leduc\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gilenya (Fingolimod): Terapia oral modificadora de la enfermedad para la esclerosis m\u00faltiple (EM)","description":"Aprenda c\u00f3mo Gilenya trata las formas recurrentes-remitentes de esclerosis m\u00faltiple. Los temas incluyen c\u00f3mo funciona el medicamento, sus efectos secundarios y m\u00e1s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/","og_locale":"es_MX","og_type":"article","og_title":"Gilenya (Fingolimod): Oral Disease-Modifying Therapy for Multiple Sclerosis (MS)","og_description":"Learn about how Gilenya treats relapsing-remitting forms of multiple sclerosis. Topics include how the drug works, side effects, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2024-08-08T23:25:10+00:00","article_modified_time":"2024-08-08T23:25:13+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg","type":"image\/jpeg"}],"author":"Dr. Christine Leduc, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Christine Leduc, PharmD","Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/"},"author":{"name":"Dr. Christine Leduc, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87"},"headline":"Gilenya (Fingolimod): Oral Disease-Modifying Therapy for Multiple Sclerosis (MS)","datePublished":"2024-08-08T23:25:10+00:00","dateModified":"2024-08-08T23:25:13+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/"},"wordCount":1014,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg","keywords":["Dr. Christine Leduc"],"articleSection":["Multiple Sclerosis"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/","url":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/","name":"Gilenya (Fingolimod): Terapia oral modificadora de la enfermedad para la esclerosis m\u00faltiple (EM)","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg","datePublished":"2024-08-08T23:25:10+00:00","dateModified":"2024-08-08T23:25:13+00:00","description":"Aprenda c\u00f3mo Gilenya trata las formas recurrentes-remitentes de esclerosis m\u00faltiple. Los temas incluyen c\u00f3mo funciona el medicamento, sus efectos secundarios y m\u00e1s.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg","width":1280,"height":853,"caption":"Doctor holding orange ribbon for multiple sclerosis awareness"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/gilenya-fingolimod-oral-disease-modifying-therapy-for-multiple-sclerosis-ms\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Gilenya (Fingolimod): Oral Disease-Modifying Therapy for Multiple Sclerosis (MS)"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87","name":"Dra. Christine Leduc, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","caption":"Dr. Christine Leduc, PharmD"},"description":"La Dra. Christine Leduc, doctora en farmacia, naci\u00f3 y creci\u00f3 en Irvine, California. Curs\u00f3 estudios universitarios en la Universidad Midwestern, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es sugerir cambios en el estilo de vida, educar a los pacientes sobre el funcionamiento de sus medicamentos y ser tutora de futuros farmac\u00e9uticos. Sus \u00e1reas de especializaci\u00f3n son la atenci\u00f3n al cliente y el conocimiento de medicamentos especializados. Tras haber trabajado en el sector servicios, ha adquirido las habilidades de atenci\u00f3n al cliente necesarias para comprender las necesidades de sus pacientes. Actualmente, la Dra. Leduc imparte clases a estudiantes de la Universidad Marshall B. Ketchum, la Universidad de Kansas y la Universidad Midwestern. En su tiempo libre, disfruta de viajar, la reposter\u00eda y la jardiner\u00eda. Ver biograf\u00eda de la autora.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"uagb_comment_info":0,"uagb_excerpt":"Gilenya is a prescription drug that is used to treat the relapsing-remitting forms of multiple sclerosis (MS) \u2014 an immune-mediated neurological disorder that occurs due to nerve damage in the brain and spinal cord.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/08\/ms-ribbon.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/multiple-sclerosis\/\" rel=\"category tag\">Multiple Sclerosis<\/a>","rttpg_excerpt":"Gilenya is a prescription drug that is used to treat the relapsing-remitting forms of multiple sclerosis (MS) \u2014 an immune-mediated neurological disorder that occurs due to nerve damage in the brain and spinal cord.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/26387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=26387"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/26387\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/26390"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=26387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=26387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=26387"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}